恒瑞医药 01276Prospectus Information

Prospectus Information
返回 Stock Info Prospectus Allotment Results Allotment Profile Expected Lots
IPO Timeline
Broker Results (T-2)
2025-05-21
Some brokers release in afternoon
Grey Market (T-1)
2025-05-22
Afternoon
HKEX Allotment (T-1)
2025-05-22
Evening
Registrar Allotment (T-1)
2025-05-22
Evening
Listing Day (T)
2025-05-23
First day of trading
Cross-Market Price Comparison
Other Listed Market Shanghai (SSE) — 恒瑞医药
Other Market Stock Code600276
H-Share Offer PriceTo be extracted
Other Market PriceLoading...
Reference Exchange RateLoading...
H-Share Offer Price Premium/Discount vs Other MarketLoading...
Company Overview
Stock Name恒瑞医药
Stock Code01276
Company Full Name恒瑞医药
Industry醫療保健
Principal Activities公司是一家根植中國、全球領先的創新型制藥企業，聚焦腫瘤、代謝和心血管疾病、免疫和呼吸系統疾病以及神經科學等領域進行新藥研發，是國內最具創新能力的制藥龍頭企業之一。
Listing Date2025-05-23
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國江蘇省連云港市經濟技術開發區昆侖山路7號
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://www.hengrui.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 44.05 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone Share41.8%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 2,126,372,790
Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 200 HK$ 8,810
2 lots 400 HK$ 17,620
3 lots 600 HK$ 26,430
4 lots 800 HK$ 35,240
5 lots 1,000 HK$ 44,050
6 lots 1,200 HK$ 52,860
7 lots 1,400 HK$ 61,670
8 lots 1,600 HK$ 70,480
9 lots 1,800 HK$ 79,290
10 lots 2,000 HK$ 88,100
15 lots 3,000 HK$ 132,150
20 lots 4,000 HK$ 176,200
25 lots 5,000 HK$ 220,250
30 lots 6,000 HK$ 264,300
35 lots 7,000 HK$ 308,350
40 lots 8,000 HK$ 352,400
45 lots 9,000 HK$ 396,450
50 lots 10,000 HK$ 440,500
100 lots 20,000 HK$ 881,000
150 lots 30,000 HK$ 1,321,500
200 lots 40,000 HK$ 1,762,000
250 lots 50,000 HK$ 2,202,500
300 lots 60,000 HK$ 2,643,000
350 lots 70,000 HK$ 3,083,500
400 lots 80,000 HK$ 3,524,000
450 lots 90,000 HK$ 3,964,500
500 lots 100,000 HK$ 4,405,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,000 lots 200,000 HK$ 8,810,000
1,500 lots 300,000 HK$ 13,215,000
2,000 lots 400,000 HK$ 17,620,000
2,500 lots 500,000 HK$ 22,025,000
3,000 lots 600,000 HK$ 26,430,000
3,500 lots 700,000 HK$ 30,835,000
4,000 lots 800,000 HK$ 35,240,000
4,500 lots 900,000 HK$ 39,645,000
5,000 lots 1,000,000 HK$ 44,050,000
10,000 lots 2,000,000 HK$ 88,100,000
15,000 lots 3,000,000 HK$ 132,150,000
20,000 lots 4,000,000 HK$ 176,200,000
25,000 lots 5,000,000 HK$ 220,250,000
30,871 lots 6,174,200 HK$ 271,973,510
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E RatioTo be extracted
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 55.15
First Day OpenHK$ 57.0
First Day Change25.20%
First Day Volume82663800.0
First Day Turnover4733500000.0
Use of Proceeds
Use of Proceeds1、約75%或7,093.4百萬港元將用于研發計劃； 2、約15%或1,418.7百萬港元將用于在中國和海外市場建設新的生產和研發設施； 3、約10%或945.8百萬港元將用作營運資金及其他一般企業用途。
Underwriting Syndicate
Joint Sponsors (3)
摩根士丹利亚洲有限公司 CE AAD291 花旗环球金融亚洲有限公司 CE AAA137 华泰金融控股（香港）有限公司 CE AOK809
Overall Coordinators (4)
摩根士丹利亚洲有限公司 CE AAD291 花旗环球金融亚洲有限公司 CE AAA137 华泰金融控股（香港）有限公司 CE AOK809 UBS Securities Hong Kong Limited CE BIN466
Joint Bookrunners (7)
摩根士丹利亚洲有限公司 CE AAD291 花旗环球金融亚洲有限公司 CE AAA137 华泰金融控股（香港）有限公司 CE AOK809 UBS Securities Hong Kong Limited CE BIN466 中银国际亚洲有限公司 CE AET863 中信里昂证券有限公司 CE AAB893 GF Securities (Hong Kong) Brokerage Limited CE AOB364
Joint Lead Managers (7)
摩根士丹利亚洲有限公司 CE AAD291 花旗环球金融亚洲有限公司 CE AAA137 华泰金融控股（香港）有限公司 CE AOK809 UBS Securities Hong Kong Limited CE BIN466 中银国际亚洲有限公司 CE AET863 中信里昂证券有限公司 CE AAB893 GF Securities (Hong Kong) Brokerage Limited CE AOB364
Cornerstone Investors
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Cordial Solar Limited 309,997,470 HKD — 3.13% — 6 months 2025-11-23
2 GIC Private Limited 2,076,992,740 HKD — 21.00% — 6 months 2025-11-23
3 Hillhouse Funds 309,997,470 HKD — 3.13% — 6 months 2025-11-23
4 Invesco Advisers, Inc 581,248,560 HKD — 5.88% — 6 months 2025-11-23
5 Millennium Capital Management (Singapore) Pte. Ltd. 232,495,900 HKD — 2.35% — 6 months 2025-11-23
6 Oaktree Funds 154,994,330 HKD — 1.57% — 6 months 2025-11-23
7 UBS Asset Management (Singapore) Ltd. 464,991,800 HKD — 4.70% — 6 months 2025-11-23
Directors & Management
Chairman孫飄揚
Company Secretary劉笑含,梁頴嫻
No director data available.
Major Shareholders
Major Shareholders & Holdings江蘇恒瑞醫藥集團有限公司(23.3%),西藏達遠企業管理有限公司(14.4%)
AI AI Analysis
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

The IPO was heavily oversubscribed at 454.85x, reflecting intense market demand. Despite this, the hit rate of 45.34% indicates a relatively high allocation rate, likely due to a large applicant pool of 203,874 individuals. The offer price was set at HK$44.05, though no range data is available for comparison. This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.

Tier Analysis

The expected allocation sharply differs between tiers: investors in the last A-tier (甲尾) receive only 0.5751 lots on average, while the first B-tier (乙头) secures exactly 1.0 lot, a 74% advantage. This wide gap suggests that applying at the B-head threshold was significantly more efficient in obtaining a full lot allocation, even after accounting for the higher capital requirement. Broker fee structures and actual costs may vary, and this analysis does not constitute investment advice. This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.

Demographics

Mainland Chinese investors dominated participation at 71.2%, typical for popular Hong Kong IPOs. The applicant base skews male (61.9%) and has an average age of 41.2, indicating a mature, likely experienced investor profile. Regional breakdowns beyond mainland vs. Hong Kong were not provided, but high mainland interest often correlates with strong sentiment. Data may contain errors or omissions from source documents — verify against official HKEX filings. This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.

AI-generated content. For informational purposes only. Not financial advice. Verify against official sources.
Subscription Tiers
IPO Timeline
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics